Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oleg Sofrygin

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Journal of the American Statistical Association|May 27, 2024
Causal Inference for Social Network DataElizabeth L Ogburn, Oleg Sofrygin, Iván Díaz, et al.
International Journal of Epidemiology|July 9, 2018
Longitudinal associations between having an adult child migrant and depressive symptoms among older adults in the Mexican Health and Aging StudyJacqueline M Torres, Kara E Rudolph, Oleg Sofrygin, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 10, 2009
Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspectiveMontserrat Vera-Llonch, Ellen Dukes, Javier Rejas, et al.
BMC Health Services Research|February 15, 2013
Technical evaluation of methods for identifying chemotherapy-induced febrile neutropenia in healthcare claims databasesDerek Weycker, Oleg Sofrygin, Kim Seefeld, et al.
Cost Effectiveness and Resource Allocation : C/E|June 1, 2017
Estimating outcomes and cost effectiveness using a single-arm clinical trial: ofatumumab for double-refractory chronic lymphocytic leukemiaAnthony J Hatswell, Gwilym J Thompson, Penny A Maroudas, et al.
Clinical Breast Cancer|June 27, 2007
Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone receptor-positive postmenopausal women with early-stage breast cancerThomas E Delea, Jon Karnon, Oleg Sofrygin, et al.
Epidemiology (Cambridge, Mass.)|April 16, 2019
Having an Adult Child in the United States, Physical Functioning, and Unmet Needs for Care Among Older Mexican AdultsJacqueline M Torres, Kara E Rudolph, Oleg Sofrygin, et al.
Pharmacoeconomics|April 4, 2007
Cost effectiveness of once-daily oral chelation therapy with deferasirox versus infusional deferoxamine in transfusion-dependent thalassaemia patients: US healthcare system perspectiveThomas E Delea, Oleg Sofrygin, Simu K Thomas, et al.
American Journal of Epidemiology|January 17, 2020
US Migration Status of Adult Children and Cognitive Decline Among Older Parents Who Remain in MexicoJacqueline M Torres, Oleg Sofrygin, Kara E Rudolph, et al.
JAMA Network Open|October 22, 2020
Assessment of Value of Neighborhood Socioeconomic Status in Models That Use Electronic Health Record Data to Predict Health Care Use Rates and MortalityAlejandro Schuler, Liam O'Súilleabháin, Gina Rinetti-Vargas, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Journal of the American Statistical Association|May 27, 2024
Causal Inference for Social Network DataElizabeth L Ogburn, Oleg Sofrygin, Iván Díaz, et al.
International Journal of Epidemiology|July 9, 2018
Longitudinal associations between having an adult child migrant and depressive symptoms among older adults in the Mexican Health and Aging StudyJacqueline M Torres, Kara E Rudolph, Oleg Sofrygin, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|June 10, 2009
Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspectiveMontserrat Vera-Llonch, Ellen Dukes, Javier Rejas, et al.
BMC Health Services Research|February 15, 2013
Technical evaluation of methods for identifying chemotherapy-induced febrile neutropenia in healthcare claims databasesDerek Weycker, Oleg Sofrygin, Kim Seefeld, et al.
Cost Effectiveness and Resource Allocation : C/E|June 1, 2017
Estimating outcomes and cost effectiveness using a single-arm clinical trial: ofatumumab for double-refractory chronic lymphocytic leukemiaAnthony J Hatswell, Gwilym J Thompson, Penny A Maroudas, et al.
Clinical Breast Cancer|June 27, 2007
Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone receptor-positive postmenopausal women with early-stage breast cancerThomas E Delea, Jon Karnon, Oleg Sofrygin, et al.
Epidemiology (Cambridge, Mass.)|April 16, 2019
Having an Adult Child in the United States, Physical Functioning, and Unmet Needs for Care Among Older Mexican AdultsJacqueline M Torres, Kara E Rudolph, Oleg Sofrygin, et al.
Pharmacoeconomics|April 4, 2007
Cost effectiveness of once-daily oral chelation therapy with deferasirox versus infusional deferoxamine in transfusion-dependent thalassaemia patients: US healthcare system perspectiveThomas E Delea, Oleg Sofrygin, Simu K Thomas, et al.
American Journal of Epidemiology|January 17, 2020
US Migration Status of Adult Children and Cognitive Decline Among Older Parents Who Remain in MexicoJacqueline M Torres, Oleg Sofrygin, Kara E Rudolph, et al.
JAMA Network Open|October 22, 2020
Assessment of Value of Neighborhood Socioeconomic Status in Models That Use Electronic Health Record Data to Predict Health Care Use Rates and MortalityAlejandro Schuler, Liam O'Súilleabháin, Gina Rinetti-Vargas, et al.
Pageof 4